Alzamend Neuro, Inc. 10-Q filing
Filed 2026-03-11 · Report date 2026-01-31 · 2026
Filing metadata
- Accession number
- 0001214659-26-003166
- Form type
- 10-Q
- CIK
- 0001677077
- Primary document
- https://www.sec.gov/Archives/edgar/data/1677077/000121465926003166/z3626110q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Alzamend Neuro, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.9M | - | - |
| Net Income | $-5.9M | - | - |
| Eps Basic | -1.89 | - | - |
| Eps Diluted | -1.89 | - | - |
| Cash And Equivalents | $2.7M | - | - |
| Total Assets | $4.0M | - | - |
| Total Liabilities | $1.9M | - | - |
| Shareholders Equity | $2.2M | - | - |
| Operating Cash Flow | $-5.3M | - | - |